EPSTEIN
page 2 / 291 . OCR, unverified
or gainiloss. Such information. which may be inaccurate. incomplete or subject to updating. should be confirmed with your records and your tax advisor.
Please take the steps Indicated below if you think statement(s) are incorrect or contact your J.P.Morgan team if you require additional information about a transaction on your
statement(s).
IMPORTANT ADDITIONAL INFORMATION APPLICABLE ONLY TO YOUR INVESTMENT MANAGEMENT ACCOUNT(S) WHICH REFLECT ASSETS HELD AT JPMORGAN CHASE BANK, N.A.
In case of other errors or questions about other account statement(s)
Please review your account statement(s) and promptly report any inaccuracy or discrepancy including possible unauthorized trading activity, unrecorded dividend payments, unaccounted cash positions,
improper payments or transfers in writing to JPMCB at the addresses shown on your statement(s). Any oral communication should be re-confirmed in writing to further protect your rights. If you have
any questions please contact your J.P. Morgan team.
In your written communication, please provide the following information: (1) your name and account number; (2) the dollar amount of the suspected error; and (3) a description of the error and
explanation, if you can, why you believe there is an error. If you need more information, you must describe the item you are unsure about. We must receive your written communication no later than 30
days after the statement on which the error or problem appeared is sent or made available. If you do not so notify us, you agree that the statement activity and account balance(s) are correct.
You must promptly advise your J.P.Morgan representative of material changes in your investment objectives or financial situation or if you wish to modify the management of your account. Unless you
inform otherwise, your J.P.Morgan representative will consider the information currently in its files to be complete and accurate.
J.P.Morgan
Disclosures Page 2 of 2
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00049809
SDNY_GM_003 19007
EFTA01522290
--- SOURCE: IMAGES__0134__EFTA01522291.txt ---
METADATA_SOURCE: IMAGES0134
METADATA_FILENAME: EFTA01522291.pdf
----------------------------------------
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00049810
SDNY_GM_00319008
EFTA01522291
--- SOURCE: IMAGES__0134__EFTA01522292.txt ---
METADATA_SOURCE: IMAGES0134
METADATA_FILENAME: EFTA01522292.pdf
----------------------------------------
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00049811
SDNY_GM_00319009
EFTA01522292
--- SOURCE: IMAGES__0134__EFTA01522293.txt ---
METADATA_SOURCE: IMAGES0134
METADATA_FILENAME: EFTA01522293.pdf
----------------------------------------
JPMorgan Chase Bank, N.A.
270 Park Avenue, New York, NY 10017-2014
GHISLAINE MAXWELL- OAP FOG
For the Period 11/
Investment Management Account
J.P. Morgan Team
Table of Contents
Page
Kirsten &oilier
Banker
212/464-0510
Account Summary
Jason Bell
Investment Specialist
21Z464-2084
Holdings
Janet Young
Client Service Team
8001634-1 31 8
Equity
Gina Magliocco
Client Service Team
Cash & Fixed Income
Online access
www.jpmorganonline.com
Portfolio Activity
Please see disclosures located at the end of this statement package for important information relating to each J.P. Morgan account(s)
J.P. Morgan
0000002530 00 0 9E 00001 Wali£04 20121204
Page 1 of 17
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00049812
SDNY_GM_00319010
EFTA01522293
--- SOURCE: IMAGES__0134__EFTA01522294.txt ---
METADATA_SOURCE: IMAGES0134
METADATA_FILENAME: EFTA01522294.pdf
----------------------------------------
GHISLAINE MAXWELL- OAP FDG
ACCT.
For the Period 11/1/12 to 11/30/12
Account Summary
Asset Allocation
Beginning
Ending
Change
Estimated
Current
Asset Allocation
Market Value
Market Value
In Value
Annual Income Allocation
Equity
176,822.04
177.692.32
870.28
5,783.57
99%
Cash 3 Foxed Income
2.473.23
1,900.70
(572.53)
0.26
1%
Market Value
$179,295.27
6178,693.02
$297.76
$5,783.83
100%
Accruals
369 05
804.78
435.73
Market Value with Accruals
5179,664.32
$180,397.80
$733.48
Portfolio Activity
Current
Period Value
Year-to-Date
Value
Beginning Market Value
InAlhdrawals 8 Fees
179.296.27
186,408.94
(1,897.50)
Net Contributions Withdrawals
$0.00
($1,697.60)
Income & Distributions
307.23
4,692.20
Change In Investment Value
(9.48)
11,389.38
Ending Market Value
$179,693.02
8179,693.02
Accruals
804.78
804.78
Market Value with Accruals
$180,397.80
$180,397.80
JP Morgan
Cash
Find Income
Page 2 of 17
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00049813
SDNY_GM_00319011
EFTA01522294
--- SOURCE: IMAGES__0134__EFTA01522295.txt ---
METADATA_SOURCE: IMAGES0134
METADATA_FILENAME: EFTA01522295.pdf
----------------------------------------
GHISLAINE MAXWELL- OAP FDG ACCT